N-[(1S)-5-{5-[3-cyano-4-(propan-2-yloxy)phenyl]-1,2,4-oxadiazol-3-yl}-1,2,3,4-tetrahydronaphthalen-1-yl]cyclopropanesulfonamide | 1307230-20-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N-[(1S)-5-{5-[3-cyano-4-(propan-2-yloxy)phenyl]-1,2,4-oxadiazol-3-yl}-1,2,3,4-tetrahydronaphthalen-1-yl]cyclopropanesulfonamide
• 英文别名: N-[(1S)-5-[5-(3-cyano-4-propan-2-yloxyphenyl)-1,2,4-oxadiazol-3-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]cyclopropanesulfonamide
• CAS: 1307230-20-1
• 化学式: C₂₅H₂₆N₄O₄S
• 分子量: 478.572
• InChiKey: PAPSSKCNFXEMPR-QFIPXVFZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  127
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• [EN] SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS<br/>[FR] MODULATEURS DU RÉCEPTEUR DE SPHINGOSINE-1-PHOSPHATE ET PROCÉDÉS DE SYNTHÈSE CHIRALE
  申请人：RECEPTOS INC

  公开号：WO2011060389A1

  公开（公告）日：2011-05-19

  Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the SlP receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.

  提供了选择性调节鞘氨醇1磷酸受体的化合物，包括调节SlP受体亚型1的化合物。提供了这类化合物的手性合成方法。与调节鞘氨醇1磷酸受体相关的治疗或预防方法，以及制备包括这些创新化合物的创新组合物的方法，用于治疗或预防需要医学干预的疾病、异常情况和疾病。
• SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS
  申请人：MARTINBOROUGH Esther

  公开号：US20110178056A1

  公开（公告）日：2011-07-21

  Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.

  提供了有选择性地调节鞘氨醇1磷酸受体的化合物，包括调节S1P受体亚型1的化合物。提供了这种化合物的手性合成方法。在调节鞘氨醇1磷酸受体在医学上被指示的疾病，异常状态和障碍的治疗或预防方面，提供了使用、治疗或预防方法以及制备创新化合物的创新组合物的方法。
• US8357706B2
  申请人：——

  公开号：US8357706B2

  公开（公告）日：2013-01-22
• US9394264B2
  申请人：——

  公开号：US9394264B2

  公开（公告）日：2016-07-19